Track topics on Twitter Track topics that are important to you
The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
The report is the result of a series of consultations with executive-level stakeholders from Ontario health organizations and industry, as well as representatives from government and other affiliate organizations.
Following a key recommendation in OBIO’s report, ‘Tackling the Anchor Company Challenge – OBIO Leadership Summit (2017),’ which highlighted the need for early adopter organizations in Ontario, the report provides a robust model for establishing, governing and supporting these organizations to best engage with innovators.
The report was launched at the Conference Board of Canada, Council on Innovation Procurement in Health Care meeting. OBIO CEO, Gail Garland, was joined by Arden Krystal, President and CEO of the Southlake Regional Health Centre, Jo-anne Marr, President & CEO of Markham Stouffville Hospital and Stefano Picone, Director of Finance of Conavi Medical.
“Today, it is clearer than ever that a model to support the early adoption of novel technologies is crucial if our health science industry is going to continue to commercialize life-saving products, create jobs and attract investment in Ontario. We are pleased to present the EAHN model as a way to achieve these benefits,” said Gail Garland, President and CEO, OBIO.
Overview of the Report:
To read ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario,’ please click here.
The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health technologies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.
Grant Burns, 416-848-6839 ext.106
Director, Public Affairs and Communications, OBIO
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...